Part­ner­ing talks led to Bio­gen’s $800M Night­star buy­out as play­ers clus­tered around the hot deal ta­ble for gene ther­a­pies

Any­one look­ing for some in­sight in­to just how hot gene ther­a­pies have be­come should turn their at­ten­tion to­day to the be­hind-the-scenes ne­go­ti­a­tions that went in­to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER